PTEN takes center stage in cancer stem cell research, works as tumor suppressor.

Journal of the National Cancer Institute

Volumn 98, Issue 12, 2006, Pages 808-809

  Hede, Karyn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, MOUSE; RAPAMYCIN;

ANIMAL; ARTICLE; CANCER STEM CELL; DISEASE MODEL; DRUG EFFECT; GENETICS; LEUKEMIA; METABOLISM; MOUSE; MUTATION; MYELOPROLIFERATIVE DISORDER;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DISEASE MODELS, ANIMAL; LEUKEMIA; MICE; MUTATION; MYELOPROLIFERATIVE DISORDERS; PTEN PHOSPHOHYDROLASE; SIROLIMUS; TUMOR STEM CELLS;

EID: 33745349313     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj270     Document Type: Article

References (0)